The article is in the Huffington Post and cites Carol Colton at Duke University School of Medicine and a drug called difluoromethylornithine (DFMO)
I didn't see any mention of inflammation
Wonder why CEO just bought 2000 shares when he has 3 million?
Company web site announces "ANAVEX 2-73 is currently in a Phase 2a study for Alzheimer’s disease, and the Company expects to report preliminary data around the Q3 2015 timeframe."
Hopefully they will have some encouraging data.
A comment in Huffington article mentions a drug equivalent to DFMO called Ornidyl on WIKI
"DMFO is available as the prescription drug Ornithyl, used to treat African sleeping sickness.
According to Wiki, Most side effects related to systemic use of Ornidyl through injection are transient and reversible by discontinuing the drug or decreasing the dose"